Risk factors and a prognostic model for postsplenectomy survival in myelofibrosis
Sign Up to like & getrecommendations! Published in 2017 at "American Journal of Hematology"
DOI: 10.1002/ajh.24881
Abstract: Palliative treatment in myelofibrosis (MF) includes transfusion support, JAK2 inhibitors, involved field radiotherapy and splenectomy. To assist in selecting patients who are likely to benefit from splenectomy, we looked into risk factors for postsplenectomy survival,… read more here.
Keywords: risk; myelofibrosis; risk factors; postsplenectomy survival ... See more keywords